Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Evaluating hemodynamic parameters in hypertensive patients during surgery

Official title: Observational Study to Evaluate the Pressure Recording Analytical Method Parameters in Patients Susceptible to Post-induction Hypotension Due to Hypertension, Diabetes Mellitus, Cardiovascular Risk Factors, or Major Surgery

Run by Recep Tayyip Erdogan University · NCT05960604 · Data updated 2026-11-12

This study is testing how well the heart works in people with high blood pressure during major surgeries to see if it can help predict and prevent low blood pressure during anesthesia.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment660 (estimated)
SponsorRecep Tayyip Erdogan University
Academic / other
Locations5 sites (Ankara and 4 other locations)
StatusRecruiting
StartedFebruary 19, 2024
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedApril 9, 2025
Trial IDNCT05960604 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are undergoing major surgery under general anesthesia and have cardiovascular risk factors such as hypertension or diabetes.

Probably not a fit

Patients who refuse to consent, have significant cardiac arrhythmias, or exhibit arterial waveform distortion may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the relationship between cardiac reserve and efficiency in hypertensive patients undergoing major surgical procedures. Utilizing the Pressure Recording Analytical Method (PRAM), the study will evaluate hemodynamic variables to identify patients at risk of hypotension during anesthesia. The investigators will build a predictive model based on these parameters to optimize patient management and improve outcomes. The study focuses on patients with cardiovascular risk factors, including hypertension and diabetes mellitus, to understand their response to surgical stress.

Why it matters

Potential benefit: If successful, this study could enhance the management of hypertensive patients during surgery, potentially reducing the incidence of hypotension and improving surgical outcomes.

How similar studies have gone: While the specific application of PRAM in hypertensive patients during surgery is novel, similar studies have shown promise in using hemodynamic monitoring to predict adverse events.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age at least 18 years
* Undergoing major surgery under general anesthesia
* Expected surgery time \>2 h
* Expected length of postoperative stay \>2 d
* Invasive blood pressure (radial or femoral) and Mostcare monitoring
* Indication for a passive leg raising test: risk of hypovolemia (preoperative fasting, bowel preparation, loss of appetite, limited access to water) or expected major surgery, expected blood loss, cardiovascular comorbidity (hypertension, diabetes mellitus, coronary artery disease, peripheral artery disease, hyperlipidemia, morbidity, active smoking).
* Recruitment after booking for surgery with sufficient time to read, understand and question study patient information prior to attending for surgery.
* Ability and willingness to provide informed consent

Exclusion Criteria:

* Refuse to consent to the study
* Arterial wave form distortion
* Cardiac arrhythmia
* Inappropriate identification of the dicrotic notch for any reason
* Planned intraoperative mean arterial blood pressure \< 65 mmHg
* Hemodynamic instability defined as mean arterial blood pressure \< 65 mmHg
* Preoperative requirement of inotrope/vasopressor infusion
* Preoperatively receiving vasoactive drugs
* Patients fitted with an intra-aortic balloon pump
* Patients fitted with Extracorporeal Membrane Oxygenation
* Critically ill patients requiring preoperative intensive care unit
* Presence of intraabdominal hypertension
* New York Heart Association Class 3-4 heart failure
* Congestive heart failure with ejection fraction \< 35%
* Glomerular filtration rate \< 30 ml/min/1.73 m2
* Ongoing renal replacement therapy

Where it's running

  • Gazi University Medical Faculty, Department of Anesthesiology and Reanimation
    Ankara, Turkey (Türkiye)
    Recruiting
  • Erzurum Atatürk University Medical Faculty, Department of Anesthesiology and Reanimation
    Erzurum, Turkey (Türkiye)
    Recruiting
  • Başakşehir Çam ve Sakura City Hospital, University Medical Faculty, Anesthesiology and Reanimation Clinic
    Istanbul, Turkey (Türkiye)
    Recruiting
  • Acıbadem University Medical Faculty, Department of Anesthesiology and Reanimation
    Istanbul, Turkey (Türkiye)
    Recruiting
  • Recep Tayyip Erdogan University Medical Faculty, Department of Anesthesiology and Reanimation
    Rize, Turkey (Türkiye)
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.